The Role of Inflammation and Fibrosis in ILD Treatment Decisions

Luca Richeldi

doi:10.1164/rccm.202401-0048pp

The Role of Inflammation and Fibrosis in ILD Treatment Decisions

Luca Richeldi

Research output: Contribution to journal › Article

Abstract

not available

Original language	English
Pages (from-to)	1-12
Number of pages	12
Journal	American Journal of Respiratory and Critical Care Medicine
Volume	2024
DOIs	https://doi.org/10.1164/rccm.202401-0048pp
Publication status	Published - 2024

Keywords

Fibrosis

Access to Document

10.1164/rccm.202401-0048pp

Cite this

@article{afb1b027e9f14fdba9e93142883d0228,

title = "The Role of Inflammation and Fibrosis in ILD Treatment Decisions",

abstract = "not available",

keywords = "Fibrosis, Fibrosis",

author = "Luca Richeldi",

year = "2024",

doi = "10.1164/rccm.202401-0048pp",

language = "English",

volume = "2024",

pages = "1--12",

journal = "American Journal of Respiratory and Critical Care Medicine",

issn = "1073-449X",

publisher = "American Thoracic Society",

}

TY - JOUR

T1 - The Role of Inflammation and Fibrosis in ILD Treatment Decisions

AU - Richeldi, Luca

PY - 2024

Y1 - 2024

N2 - not available

AB - not available

KW - Fibrosis

UR - http://hdl.handle.net/10807/269639

U2 - 10.1164/rccm.202401-0048pp

DO - 10.1164/rccm.202401-0048pp

M3 - Article

SN - 1073-449X

VL - 2024

SP - 1

EP - 12

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

ER -

The Role of Inflammation and Fibrosis in ILD Treatment Decisions

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this